vs
Cytek Biosciences, Inc.（CTKB）与Perimeter Solutions, Inc.（PRM）财务数据对比。点击上方公司名可切换其他公司
Perimeter Solutions, Inc.的季度营收约是Cytek Biosciences, Inc.的1.7倍（$102.8M vs $62.1M），Cytek Biosciences, Inc.净利率更高（-70.9% vs -136.5%，领先65.5%），Perimeter Solutions, Inc.同比增速更快（19.2% vs 8.1%），Perimeter Solutions, Inc.自由现金流更多（$11.6M vs $-1.8M），过去两年Perimeter Solutions, Inc.的营收复合增速更高（31.9% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
Perimeter Solutions是一家以色列云与网络安全企业，专为各类机构打造基于零信任架构的安全远程网络方案，其技术可替代VPN、防火墙等传统安全硬件设备，助力企业简化网络安全部署，提升远程访问的安全性与效率。
CTKB vs PRM — 直观对比
营收规模更大
PRM
是对方的1.7倍
$62.1M
营收增速更快
PRM
高出11.0%
8.1%
净利率更高
CTKB
高出65.5%
-136.5%
自由现金流更多
PRM
多$13.4M
$-1.8M
两年增速更快
PRM
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $102.8M |
| 净利润 | $-44.1M | $-140.2M |
| 毛利率 | 52.9% | 45.2% |
| 营业利润率 | -9.0% | -160.7% |
| 净利率 | -70.9% | -136.5% |
| 营收同比 | 8.1% | 19.2% |
| 净利润同比 | -557.1% | -197.3% |
| 每股收益（稀释后） | — | $-0.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBPRM
| Q4 25 | $62.1M | $102.8M | ||
| Q3 25 | $52.3M | $315.4M | ||
| Q2 25 | $45.6M | $162.6M | ||
| Q1 25 | $41.5M | $72.0M | ||
| Q4 24 | $57.5M | $86.2M | ||
| Q3 24 | $51.5M | $288.4M | ||
| Q2 24 | $46.6M | $127.3M | ||
| Q1 24 | $44.9M | $59.0M |
净利润CTKBPRM
| Q4 25 | $-44.1M | $-140.2M | ||
| Q3 25 | $-5.5M | $-90.7M | ||
| Q2 25 | $-5.6M | $-32.2M | ||
| Q1 25 | $-11.4M | $56.7M | ||
| Q4 24 | $9.6M | $144.2M | ||
| Q3 24 | $941.0K | $-89.2M | ||
| Q2 24 | $-10.4M | $21.6M | ||
| Q1 24 | $-6.2M | $-82.6M |
毛利率CTKBPRM
| Q4 25 | 52.9% | 45.2% | ||
| Q3 25 | 52.7% | 63.1% | ||
| Q2 25 | 52.3% | 62.4% | ||
| Q1 25 | 48.6% | 39.1% | ||
| Q4 24 | 58.5% | 48.6% | ||
| Q3 24 | 56.3% | 62.8% | ||
| Q2 24 | 54.6% | 57.6% | ||
| Q1 24 | 51.3% | 35.1% |
营业利润率CTKBPRM
| Q4 25 | -9.0% | -160.7% | ||
| Q3 25 | -17.6% | -27.7% | ||
| Q2 25 | -23.3% | -16.1% | ||
| Q1 25 | -36.1% | — | ||
| Q4 24 | 5.2% | 71.1% | ||
| Q3 24 | -8.2% | -12.2% | ||
| Q2 24 | -18.3% | 35.4% | ||
| Q1 24 | -23.9% | -126.8% |
净利率CTKBPRM
| Q4 25 | -70.9% | -136.5% | ||
| Q3 25 | -10.5% | -28.7% | ||
| Q2 25 | -12.2% | -19.8% | ||
| Q1 25 | -27.5% | 78.7% | ||
| Q4 24 | 16.8% | 167.2% | ||
| Q3 24 | 1.8% | -30.9% | ||
| Q2 24 | -22.4% | 17.0% | ||
| Q1 24 | -13.8% | -139.8% |
每股收益（稀释后）CTKBPRM
| Q4 25 | — | $-0.89 | ||
| Q3 25 | — | $-0.62 | ||
| Q2 25 | — | $-0.22 | ||
| Q1 25 | — | $0.36 | ||
| Q4 24 | — | $1.00 | ||
| Q3 24 | — | $-0.61 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $-0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $325.9M |
| 总债务越低越好 | — | $669.1M |
| 股东权益账面价值 | $341.7M | $1.1B |
| 总资产 | $461.5M | $2.7B |
| 负债/权益比越低杠杆越低 | — | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资CTKBPRM
| Q4 25 | $90.9M | $325.9M | ||
| Q3 25 | $93.3M | $340.6M | ||
| Q2 25 | $75.5M | $140.7M | ||
| Q1 25 | $95.3M | $200.1M | ||
| Q4 24 | $98.7M | $198.5M | ||
| Q3 24 | $162.3M | $223.1M | ||
| Q2 24 | $177.9M | $43.2M | ||
| Q1 24 | $168.8M | $38.7M |
总债务CTKBPRM
| Q4 25 | — | $669.1M | ||
| Q3 25 | — | $668.8M | ||
| Q2 25 | — | $668.4M | ||
| Q1 25 | — | $668.1M | ||
| Q4 24 | — | $667.8M | ||
| Q3 24 | — | $667.4M | ||
| Q2 24 | — | $667.1M | ||
| Q1 24 | — | $666.8M |
股东权益CTKBPRM
| Q4 25 | $341.7M | $1.1B | ||
| Q3 25 | $378.6M | $1.1B | ||
| Q2 25 | $377.6M | $1.2B | ||
| Q1 25 | $379.6M | $1.2B | ||
| Q4 24 | $395.7M | $1.2B | ||
| Q3 24 | $385.5M | $1.0B | ||
| Q2 24 | $389.1M | $1.1B | ||
| Q1 24 | $392.6M | $1.1B |
总资产CTKBPRM
| Q4 25 | $461.5M | $2.7B | ||
| Q3 25 | $494.9M | $2.6B | ||
| Q2 25 | $493.3M | $2.5B | ||
| Q1 25 | $482.6M | $2.4B | ||
| Q4 24 | $499.5M | $2.4B | ||
| Q3 24 | $491.2M | $2.5B | ||
| Q2 24 | $483.7M | $2.3B | ||
| Q1 24 | $492.1M | $2.3B |
负债/权益比CTKBPRM
| Q4 25 | — | 0.59× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.62× | ||
| Q1 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $18.6M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $11.6M |
| 自由现金流率自由现金流/营收 | -2.9% | 11.3% |
| 资本支出强度资本支出/营收 | 1.6% | 6.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $208.6M |
8季度趋势，按日历期对齐
经营现金流CTKBPRM
| Q4 25 | $-771.0K | $18.6M | ||
| Q3 25 | $-3.9M | $198.7M | ||
| Q2 25 | $108.0K | $-2.9M | ||
| Q1 25 | $-125.0K | $23.7M | ||
| Q4 24 | $2.0M | $-6.0M | ||
| Q3 24 | $13.2M | $183.0M | ||
| Q2 24 | $6.2M | $8.6M | ||
| Q1 24 | $4.0M | $2.8M |
自由现金流CTKBPRM
| Q4 25 | $-1.8M | $11.6M | ||
| Q3 25 | $-4.6M | $193.6M | ||
| Q2 25 | $-1.5M | $-15.6M | ||
| Q1 25 | $-974.0K | $18.9M | ||
| Q4 24 | $1.1M | $-12.4M | ||
| Q3 24 | $12.2M | $179.1M | ||
| Q2 24 | $5.2M | $5.0M | ||
| Q1 24 | $3.4M | $1.2M |
自由现金流率CTKBPRM
| Q4 25 | -2.9% | 11.3% | ||
| Q3 25 | -8.7% | 61.4% | ||
| Q2 25 | -3.2% | -9.6% | ||
| Q1 25 | -2.3% | 26.3% | ||
| Q4 24 | 1.9% | -14.4% | ||
| Q3 24 | 23.7% | 62.1% | ||
| Q2 24 | 11.0% | 3.9% | ||
| Q1 24 | 7.6% | 2.1% |
资本支出强度CTKBPRM
| Q4 25 | 1.6% | 6.8% | ||
| Q3 25 | 1.3% | 1.6% | ||
| Q2 25 | 3.5% | 7.8% | ||
| Q1 25 | 2.0% | 6.7% | ||
| Q4 24 | 1.6% | 7.5% | ||
| Q3 24 | 2.0% | 1.3% | ||
| Q2 24 | 2.3% | 2.9% | ||
| Q1 24 | 1.3% | 2.6% |
现金转化率CTKBPRM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | 0.21× | -0.04× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 0.40× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PRM
| Products | $87.7M | 85% |
| Service And Other | $14.8M | 14% |
